100%; P ¼ .92), with similar rates of adjunctive procedures in the two groups (20% vs 11%; P ¼ .35). The mean hospital stay was 7.4 6 4.6 days for open repair and 4.6 6 2 days for EVAR (P ¼ .28). There were no differences in terms of perioperative mortality (5% vs 0%; P ¼ .41). The mean follow-up was 63.2 6 54.4 months for group 1 and 70.8 6 44.3 for group 2 (P ¼ .39). Significantly lower mean levels of postoperative serum creatinine were found in the open surgery group (1.43 6 1.09 vs 2.02 6 1.32 in group 2; P ¼ .01) during follow-up. There was a significantly lower 60month estimated freedom from aneurysm-related reintervention (87.5%; standard error [SE], .02 vs 80%; SE, .09; P ¼ .019) (Fig) for group 2, whereas there were no differences in terms of estimated 60-month survival measured with Kaplan-Meier curves and log-rank test (75.6%; SE, .03 vs 85.6%; SE, .09; P ¼ .42).Conclusions: In this monocentric experience, endovascular management of iAAA provided good results in terms of perioperative and 60month survival, but with significant worsening of renal function and a higher reintervention rate when compared with open repair, which still remains, in our opinion, the gold standard treatment option for this disease. This study has significant limitations: it is a nonrandomized, monocentric, retrospective experience, and the EVAR group is significantly smaller than the open repair group.
Objectives: We reviewed a consecutive series of patients who had arteriovenous fistula (AVF) placement in advance of starting hemodialysis and sought to determine what factors were associated with failure of the AVF to be ready for use, which required patients to start dialysis with a tunneled dialysis catheter (TDC).Methods: We analyzed all patients who had an AVF placed at our institution from 2013 to 2018 using data from the Vascular Quality Initiative database and retrospective chart review. The primary study group included patients who had an AVF placed in advance of needing hemodialysis. Patients were categorized as "Success": AVF placement with hemodialysis initiated using the AVF or "Failure": AVF placement with hemodialysis initiated using a TDC.Results: Of the 46 patients reviewed, 26 (56.5%) were classified as "Failure." Preoperative factors associated with failure included: uremia (5% of success group vs 26.9% of failure group; P ¼ .031), uremic males (37.5% of uremic male patients failed vs 0% of uremic females; P ¼ .007), history of coronary artery disease among males (success, 8.33% vs fail, 50%; P ¼ .04), and history of percutaneous coronary intervention among males (fail male, 25% vs fail female, 0%; P ¼ .030).Conclusions: In our series of patients referred for AVF placement prior to starting dialysis, we noted an unexpectedly high rate of hemodialysis initiation with a TDC. This study suggests that patientrelated factors such as uremia and a history of coronary artery disease or intervention may be associated with failure of the AVF to be ready for hemodialysis. Further work building from findings in this study may help with patient selection decisions to minimize the need to initiate hemodialysis with a TDC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.